Technical Analysis for BBLG - Bone Biologics Corp
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.66 | 7.10% | 0.11 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 7.10% | |
| Gapped Up | Strength | 7.10% | |
| Oversold Stochastic | Weakness | 7.10% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 7.10% | |
| NR7 | Range Contraction | 7.10% | |
| Narrow Range Bar | Range Contraction | 7.10% |
| Alert | Time |
|---|---|
| 10 DMA Resistance | 2 days ago |
| Up 3% | 2 days ago |
| Up 2% | 2 days ago |
| Up 1% | 2 days ago |
| Down 3% | 3 days ago |
Get a Trading Sidekick!
- Earnings date: 05/13/2024
Bone Biologics Corp Description
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biopharmaceutical Clinical Medicine Surgery Neurosurgery Platform Technology Orthopedic Surgery Sports Medicine Surgical Specialties Spinal Fusion Degenerative Disc Disease Spinal Fusion Applications
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 55.12 |
| 52 Week Low | 1.38 |
| Average Volume | 69,193 |
| 200-Day Moving Average | 3.60 |
| 50-Day Moving Average | 1.79 |
| 20-Day Moving Average | 1.78 |
| 10-Day Moving Average | 1.60 |
| Average True Range | 0.25 |
| RSI (14) | 46.24 |
| ADX | 21.52 |
| +DI | 23.41 |
| -DI | 17.81 |
| Chandelier Exit (Long, 3 ATRs) | 2.41 |
| Chandelier Exit (Short, 3 ATRs) | 2.12 |
| Upper Bollinger Bands | 2.28 |
| Lower Bollinger Band | 1.29 |
| Percent B (%b) | 0.37 |
| BandWidth | 55.35 |
| MACD Line | -0.08 |
| MACD Signal Line | -0.06 |
| MACD Histogram | -0.0214 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.81 | ||||
| Resistance 3 (R3) | 1.79 | 1.73 | 1.79 | ||
| Resistance 2 (R2) | 1.73 | 1.69 | 1.74 | 1.78 | |
| Resistance 1 (R1) | 1.69 | 1.66 | 1.71 | 1.71 | 1.77 |
| Pivot Point | 1.63 | 1.63 | 1.64 | 1.64 | 1.63 |
| Support 1 (S1) | 1.59 | 1.59 | 1.61 | 1.61 | 1.55 |
| Support 2 (S2) | 1.53 | 1.56 | 1.54 | 1.54 | |
| Support 3 (S3) | 1.49 | 1.53 | 1.54 | ||
| Support 4 (S4) | 1.51 |
